statistiche ricercatore

Continente	#
EU - Europa	18.783
NA - Nord America	804
AS - Asia	314
Continente sconosciuto - Info sul continente non disponibili	47
SA - Sud America	39
AF - Africa	10
OC - Oceania	4
Totale	20.001

Nazione	#
IT - Italia	18.447
US - Stati Uniti d'America	789
GB - Regno Unito	119
CN - Cina	112
SG - Singapore	102
DE - Germania	61
SE - Svezia	49
VN - Vietnam	42
UA - Ucraina	37
BR - Brasile	28
FI - Finlandia	21
FR - Francia	19
HK - Hong Kong	13
IN - India	12
CA - Canada	7
IQ - Iraq	7
BE - Belgio	6
RO - Romania	5
ZA - Sudafrica	5
AR - Argentina	4
AU - Australia	4
BD - Bangladesh	4
ID - Indonesia	4
MX - Messico	4
AT - Austria	3
PK - Pakistan	3
RU - Federazione Russa	3
TH - Thailandia	3
DK - Danimarca	2
JP - Giappone	2
PE - Perù	2
PL - Polonia	2
PY - Paraguay	2
RS - Serbia	2
SA - Arabia Saudita	2
TR - Turchia	2
AL - Albania	1
AO - Angola	1
BH - Bahrain	1
CL - Cile	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EC - Ecuador	1
EG - Egitto	1
IE - Irlanda	1
IL - Israele	1
IR - Iran	1
JM - Giamaica	1
JO - Giordania	1
KR - Corea	1
LY - Libia	1
MD - Moldavia	1
MK - Macedonia	1
NO - Norvegia	1
OM - Oman	1
PA - Panama	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TN - Tunisia	1
VE - Venezuela	1
Totale	19.954

Nome	#
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis	4.592
Killer cell immunoglobulin-like receptors and their HLA class I ligands in autoimmune hepatitis: a possible pathogenetic role ?	3.152
Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?	2.957
Role of interferon lambda 4 and ALT levels in optimising treatment of HCV for patients with low-stage fibrosis	2.851
Combination of IFNL4 polymorphisms and ALT reduction at 4 week of treatment with PEG IFN and Ribavirin is a new selection tool to optimize antiviral treatment allocation in HCV patients with low stage fibrosis	2.559
INFLUENZA DEI POLIMORFISMI DELL’INTERFERONE LAMBDA NELLA STORIA NATURALE DELLA INFEZIONE CRONICA DA HBV: COINCIDENZA O REALTÀ?	2.320
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians	1.570
Totale	20.001

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	526	0	0	0	0	88	42	25	29	113	93	94	42
2022/2023	920	88	174	173	75	84	62	23	74	36	40	57	34
2023/2024	978	60	102	47	75	86	148	127	62	61	53	85	72
2024/2025	1.149	144	262	153	174	100	107	120	8	21	15	24	21
2025/2026	605	61	16	131	26	47	50	104	24	42	67	24	13
2026/2027	105	9	17	34	39	6	0	0	0	0	0	0	0
Totale													20.001

UNICA IRIS Institutional Research Information System